PRGO
PERRIGO Co plc
Company overview
- Market capitalization
- $2.10B
- Employees
- 8,100
- Latest publication
- 2026-09-29
About PERRIGO Co plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-27 · USD | Q4 20252025-12-31 · USD | Q3 20232023-09-30 · USD | Q2 20232023-06-30 · USD | Q4 20222022-12-31 · USD | Q3 20222022-09-30 · USD | Q2 20222022-06-30 · USD | Q1 20222022-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,022,800,000USD | 1,109,600,000USD | 1,123,800,000USD | 1,193,100,000USD | 1,155,300,000USD | 1,100,200,000USD | 1,121,700,000USD | 1,074,500,000USD |
| Cost Of Revenue | 708,900,000USD | 747,400,000USD | 712,600,000USD | 765,100,000USD | 772,700,000USD | 737,300,000USD | 749,600,000USD | 736,700,000USD |
| Gross Profit | 313,900,000USD | 362,200,000USD | 411,200,000USD | 428,000,000USD | 382,600,000USD | 362,900,000USD | 372,100,000USD | 337,800,000USD |
| Research Development | 23,700,000USD | 21,800,000USD | 29,600,000USD | 32,200,000USD | 32,600,000USD | 29,800,000USD | 31,500,000USD | 29,300,000USD |
| Selling And Marketing Expenses | 129,500,000USD | — | 178,000,000USD | 199,700,000USD | 182,300,000USD | 175,100,000USD | 180,300,000USD | 160,000,000USD |
| General And Administrative Expenses | 100,000,000USD | — | — | — | — | — | — | — |
| Total Operating Expenses | 290,500,000USD | 277,500,000USD | 349,100,000USD | 371,200,000USD | 351,600,000USD | 329,800,000USD | 379,000,000USD | 316,100,000USD |
| Operating Income | 23,500,000USD | 84,700,000USD | 62,100,000USD | 56,800,000USD | 31,000,000USD | 33,100,000USD | -6,900,000USD | 21,700,000USD |
| Total Other Income Expense Net | 81,900,000USD | -1,416,400,000USD | -42,900,000USD | -34,300,000USD | -45,300,000USD | -36,600,000USD | -101,400,000USD | -34,700,000USD |
| Income Before Tax | 105,400,000USD | -1,331,700,000USD | 19,200,000USD | 22,500,000USD | -14,300,000USD | -3,500,000USD | -108,300,000USD | -13,000,000USD |
| Income Tax Expense | 16,900,000USD | 82,800,000USD | 3,800,000USD | 13,600,000USD | -1,600,000USD | 48,600,000USD | -43,400,000USD | -11,700,000USD |
| Discontinued Operations | -14,100,000USD | — | -1,200,000USD | -500,000USD | -11,000,000USD | 2,700,000USD | -200,000USD | -1,100,000USD |
| Net Income | 74,500,000USD | -1,418,100,000USD | 14,200,000USD | 8,400,000USD | -23,700,000USD | -49,400,000USD | -65,100,000USD | -2,400,000USD |
| Selling General Administrative | — | 319,400,000USD | 126,000,000USD | 132,600,000USD | 126,300,000USD | 105,900,000USD | 157,800,000USD | 122,300,000USD |
| Unclassified Operating Expenses | — | -63,700,000USD | 15,500,000USD | 6,700,000USD | 10,400,000USD | 19,000,000USD | 9,400,000USD | 4,500,000USD |
| Interest Expense | — | 29,900,000USD | 43,500,000USD | 44,000,000USD | 40,900,000USD | 41,000,000USD | 38,300,000USD | 35,800,000USD |
| Net Interest Income | — | -43,300,000USD | -43,500,000USD | -44,000,000USD | -40,900,000USD | -41,000,000USD | -38,300,000USD | -35,800,000USD |
| Tax Provision | — | 82,900,000USD | 3,800,000USD | 13,600,000USD | -1,600,000USD | 48,600,000USD | -43,400,000USD | -11,700,000USD |
| Net Income From Continuing Ops | — | -1,414,600,000USD | 15,400,000USD | 8,900,000USD | -12,700,000USD | -52,100,000USD | -64,900,000USD | -1,300,000USD |
| Ebit | — | -1,301,800,000USD | 62,700,000USD | 66,500,000USD | 26,600,000USD | 37,500,000USD | -70,000,000USD | 22,800,000USD |
| Ebitda | — | -1,246,100,000USD | 153,700,000USD | 160,400,000USD | 123,700,000USD | 126,000,000USD | 13,500,000USD | 92,300,000USD |
| Depreciation And Amortization | — | 55,700,000USD | 91,000,000USD | 93,900,000USD | 97,100,000USD | 88,500,000USD | 83,500,000USD | 69,500,000USD |
| Reconciled Depreciation | — | 85,900,000USD | 91,000,000USD | 93,900,000USD | 97,100,000USD | 88,500,000USD | 83,500,000USD | 69,500,000USD |
| Net Income Applicable To Common Shares | — | — | 14,200,000USD | 8,400,000USD | -23,700,000USD | -49,400,000USD | -65,100,000USD | -2,400,000USD |
| Non Operating Income Net Other | — | — | — | 9,700,000USD | — | 4,400,000USD | -63,100,000USD | 1,100,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD | FY 20152015-12-31 · USD | FY 20142014-12-31 · USD | FY 20132013-12-31 · USD | FY 20122012-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,451,600,000USD | 4,138,700,000USD | 4,946,200,000USD | 5,280,600,000USD | 4,603,900,000USD | 4,060,800,000USD | 4,060,800,000USD | 3,539,800,000USD |
| Cost Of Revenue | 2,996,200,000USD | 2,722,500,000USD | 2,966,700,000USD | 3,228,800,000USD | 2,891,500,000USD | 2,613,100,000USD | 2,613,100,000USD | 2,259,800,000USD |
| Gross Profit | 1,455,400,000USD | 1,416,200,000USD | 1,979,500,000USD | 2,051,800,000USD | 1,712,400,000USD | 1,447,700,000USD | 1,447,700,000USD | 1,280,000,000USD |
| Research Development | 123,100,000USD | 122,000,000USD | 167,700,000USD | 184,000,000USD | 187,800,000USD | 152,500,000USD | 152,500,000USD | 115,200,000USD |
| Selling General Administrative | 512,300,000USD | 482,000,000USD | 461,100,000USD | 452,200,000USD | 385,200,000USD | 411,300,000USD | 466,600,000USD | 426,300,000USD |
| Selling And Marketing Expenses | 697,800,000USD | — | — | 753,300,000USD | 386,600,000USD | 263,900,000USD | 208,600,000USD | 47,500,000USD |
| Unclassified Operating Expenses | 43,300,000USD | 401,800,000USD | 644,000,000USD | — | — | — | 218,800,000USD | — |
| Total Operating Expenses | 1,376,500,000USD | 1,005,800,000USD | 1,272,800,000USD | 1,389,500,000USD | 959,600,000USD | 827,700,000USD | 1,046,500,000USD | 589,000,000USD |
| Operating Income | 78,900,000USD | 410,400,000USD | 598,200,000USD | -1,999,700,000USD | 747,600,000USD | 567,000,000USD | 401,200,000USD | 679,100,000USD |
| Interest Expense | 156,000,000USD | 125,000,000USD | 173,400,000USD | 218,800,000USD | 155,700,000USD | 175,800,000USD | 0USD | 103,500,000USD |
| Net Interest Income | -156,000,000USD | -125,000,000USD | -168,100,000USD | -216,600,000USD | — | — | — | — |
| Income Before Tax | -139,100,000USD | 258,700,000USD | 280,100,000USD | -4,848,300,000USD | 248,000,000USD | 272,600,000USD | 272,600,000USD | 607,700,000USD |
| Income Tax Expense | -8,200,000USD | 389,600,000USD | 160,500,000USD | -835,500,000USD | 120,100,000USD | 67,300,000USD | 67,300,000USD | 165,800,000USD |
| Tax Provision | -8,200,000USD | 389,600,000USD | 160,500,000USD | -835,500,000USD | -33,600,000USD | — | — | — |
| Net Income | -140,600,000USD | -68,900,000USD | 119,600,000USD | -4,012,800,000USD | 127,900,000USD | 205,300,000USD | 205,300,000USD | 441,900,000USD |
| Net Income From Continuing Ops | -130,900,000USD | -130,900,000USD | 119,600,000USD | -4,012,800,000USD | -1,900,000USD | 711,200,000USD | 205,300,000USD | 441,900,000USD |
| Ebit | 16,900,000USD | 383,700,000USD | 692,500,000USD | -4,637,900,000USD | 205,500,000USD | 851,500,000USD | 401,200,000USD | 779,200,000USD |
| Ebitda | 355,500,000USD | 695,900,000USD | 1,137,300,000USD | -4,180,900,000USD | 754,300,000USD | 1,210,400,000USD | 760,100,000USD | 939,400,000USD |
| Depreciation And Amortization | 338,600,000USD | 312,200,000USD | 444,800,000USD | 457,000,000USD | 548,800,000USD | 358,900,000USD | 358,900,000USD | 160,200,000USD |
| Reconciled Depreciation | 338,600,000USD | 312,200,000USD | 444,800,000USD | — | — | — | — | — |
| Total Other Income Expense Net | -218,000,000USD | -151,700,000USD | -318,100,000USD | -2,848,600,000USD | -499,600,000USD | -412,200,000USD | -12,400,000USD | -267,800,000USD |
| Discontinued Operations | -9,700,000USD | 62,000,000USD | — | — | — | — | — | — |
| Net Income Applicable To Common Shares | -140,600,000USD | -68,900,000USD | 119,600,000USD | -4,012,800,000USD | 42,500,000USD | 128,000,000USD | 205,300,000USD | 441,900,000USD |
| Non Operating Income Net Other | — | -26,700,000USD | -150,000,000USD | -2,632,000,000USD | — | -10,500,000USD | -178,200,000USD | — |
| Interest Income | — | — | 154,500,000USD | 218,500,000USD | 97,900,000USD | — | — | — |
| Minority Interest | — | — | 100,000USD | -500,000USD | -600,000USD | 200,000USD | 800,000USD | 1,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-27 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,609,500,000USD | 7,983,300,000USD | 8,535,200,000USD | 10,084,000,000USD | 10,094,100,000USD | 9,759,800,000USD | 9,647,700,000USD | 11,203,200,000USD |
| Cash And Equivalents | 399,700,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 2,451,700,000USD | 2,712,400,000USD | 2,797,400,000USD | 2,879,200,000USD | 2,615,000,000USD | 2,533,000,000USD | 2,481,900,000USD | 3,707,800,000USD |
| Other Current Assets | 277,700,000USD | 501,000,000USD | 504,000,000USD | 544,500,000USD | 238,700,000USD | 251,300,000USD | 199,000,000USD | 325,700,000USD |
| Other Non Current Assets | 258,600,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,093,700,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,054,800,000USD | 997,600,000USD | 1,012,900,000USD | 1,145,300,000USD | 1,126,100,000USD | 1,073,800,000USD | 1,044,200,000USD | 1,450,500,000USD |
| Other Non Current Liabilities | 608,800,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 2,515,800,000USD | 2,498,800,000USD | 2,935,500,000USD | 4,446,500,000USD | 4,472,300,000USD | 4,364,000,000USD | 4,319,400,000USD | 4,566,000,000USD |
| Total Equity Including Noncontrolling Interest | 2,515,800,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 11,400,000USD | 11,400,000USD | 36,600,000USD | 36,600,000USD | 36,400,000USD | 36,200,000USD | 36,400,000USD | 440,700,000USD |
| Long Term Debt | 3,283,400,000USD | 3,621,100,000USD | 3,603,600,000USD | 3,608,100,000USD | 3,615,500,000USD | 3,591,300,000USD | 3,581,700,000USD | 4,312,600,000USD |
| Net Receivables | 709,900,000USD | 732,800,000USD | 612,800,000USD | 675,600,000USD | 706,600,000USD | 716,800,000USD | 642,300,000USD | 785,900,000USD |
| Inventory | 1,064,500,000USD | 1,121,400,000USD | 1,149,000,000USD | 1,227,000,000USD | 1,215,500,000USD | 1,155,000,000USD | 1,081,800,000USD | 1,133,800,000USD |
| Property Plant Equipment Net | 849,000,000USD | 1,040,000,000USD | 1,066,500,000USD | 1,083,700,000USD | 1,097,700,000USD | 1,083,300,000USD | 1,093,000,000USD | 1,091,300,000USD |
| Accounts Payable | 400,400,000USD | 434,800,000USD | 474,500,000USD | 469,700,000USD | 489,000,000USD | 502,300,000USD | 495,200,000USD | 458,500,000USD |
| Common Stock | 6,540,500,000USD | 6,578,100,000USD | 6,608,200,000USD | 6,636,300,000USD | 6,664,200,000USD | 6,692,900,000USD | 6,733,900,000USD | 6,763,900,000USD |
| Retained Earnings | -4,001,900,000USD | -4,076,300,000USD | -3,677,500,000USD | -2,259,400,000USD | -2,266,900,000USD | -2,258,500,000USD | -2,252,100,000USD | -2,207,700,000USD |
| Accumulated Other Comprehensive Income | -22,800,000USD | -3,000,000USD | 14,100,000USD | 69,600,000USD | 75,000,000USD | -70,400,000USD | -162,400,000USD | 9,800,000USD |
| Intangible Assets | — | 2,263,900,000USD | 2,351,500,000USD | 2,405,500,000USD | 2,563,500,000USD | 2,462,000,000USD | 2,428,900,000USD | 2,660,800,000USD |
| Total Liab | — | 5,484,500,000USD | 5,599,700,000USD | 5,637,500,000USD | 5,621,800,000USD | 5,395,800,000USD | 5,328,300,000USD | 6,637,200,000USD |
| Other Current Liab | — | 496,700,000USD | 455,300,000USD | 610,600,000USD | 561,500,000USD | 520,900,000USD | 495,200,000USD | 541,300,000USD |
| Capital Stock | — | 6,578,100,000USD | 6,608,200,000USD | 6,636,300,000USD | 6,664,200,000USD | 6,692,900,000USD | 6,733,900,000USD | 6,763,900,000USD |
| Good Will | — | 1,701,800,000USD | 2,050,100,000USD | 3,360,400,000USD | 3,479,200,000USD | 3,375,200,000USD | 3,320,200,000USD | 3,421,400,000USD |
| Cash | — | 357,200,000USD | 531,600,000USD | 432,100,000USD | 454,200,000USD | 409,900,000USD | 558,800,000USD | 1,462,400,000USD |
| Cash And Short Term Investments | — | 357,200,000USD | 531,600,000USD | 432,100,000USD | 454,200,000USD | 409,900,000USD | 558,800,000USD | 1,462,400,000USD |
| Net Debt | — | 3,448,100,000USD | 3,437,300,000USD | 3,394,100,000USD | 3,378,900,000USD | 3,217,600,000USD | 3,059,300,000USD | 3,290,900,000USD |
| Short Term Debt | — | 37,500,000USD | 62,300,000USD | 65,000,000USD | 65,300,000USD | 36,200,000USD | 36,400,000USD | 440,700,000USD |
| Short Long Term Debt Total | — | 3,805,300,000USD | 3,968,900,000USD | 3,826,200,000USD | 3,833,100,000USD | 3,627,500,000USD | 3,618,100,000USD | 4,753,300,000USD |
| Property Plant Equipment Gross | — | 1,040,000,000USD | 2,326,000,000USD | 1,072,900,000USD | 1,086,700,000USD | 1,083,300,000USD | 2,234,600,000USD | 1,091,300,000USD |
| Common Stock Shares Outstanding | — | 138,700,000shares | 138,500,000shares | 138,900,000shares | 138,200,000shares | 137,700,000shares | 137,600,000shares | 137,500,000shares |
| Non Current Assets Total | — | 5,270,900,000USD | 5,737,800,000USD | 7,204,800,000USD | 7,479,100,000USD | 7,226,800,000USD | 7,165,800,000USD | 7,495,400,000USD |
| Non Current Liabilities Total | — | 4,486,900,000USD | 4,586,800,000USD | 4,492,200,000USD | 4,495,700,000USD | 4,322,000,000USD | 4,284,100,000USD | 5,186,700,000USD |
| Non Current Liabilities Other | — | 712,300,000USD | 814,300,000USD | 689,700,000USD | 673,400,000USD | 541,500,000USD | 499,200,000USD | 660,300,000USD |
| Non Currrent Assets Other | — | 233,300,000USD | 236,400,000USD | 231,100,000USD | 229,300,000USD | 300,900,000USD | 318,600,000USD | 299,500,000USD |
| Net Working Capital | — | 1,714,800,000USD | 1,784,500,000USD | 1,733,900,000USD | 1,488,900,000USD | 1,459,200,000USD | 1,437,700,000USD | 2,257,300,000USD |
| Unclassified Current Liabilities | — | 17,200,000USD | -15,800,000USD | -36,600,000USD | -26,100,000USD | -21,800,000USD | -19,000,000USD | -440,700,000USD |
| Unclassified Non Current Liabilities | — | 153,500,000USD | 168,900,000USD | 194,400,000USD | 206,800,000USD | 189,200,000USD | 203,200,000USD | 213,800,000USD |
| Unclassified Equity | — | -6,578,100,000USD | -6,617,500,000USD | -6,636,300,000USD | -6,664,200,000USD | -6,692,900,000USD | -6,733,900,000USD | -6,763,900,000USD |
| Unclassified Non Current Assets | — | — | — | 124,100,000USD | 109,400,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 10,000,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 8,535,200,000USD | 9,647,700,000USD | 10,809,100,000USD | 11,017,300,000USD | 10,425,700,000USD | 11,488,400,000USD | 11,301,400,000USD | 10,983,400,000USD |
| Intangible Assets | 2,351,500,000USD | 2,428,900,000USD | 2,986,100,000USD | 3,288,800,000USD | 2,151,400,000USD | 2,488,500,000USD | 2,990,000,000USD | 2,858,900,000USD |
| Other Current Assets | 504,000,000USD | 199,000,000USD | 201,100,000USD | 271,800,000USD | 321,900,000USD | 849,100,000USD | 165,800,000USD | 400,000,000USD |
| Total Liab | 5,599,700,000USD | 5,328,300,000USD | 6,041,200,000USD | 6,175,200,000USD | 5,274,000,000USD | 5,833,300,000USD | 5,497,300,000USD | 5,315,300,000USD |
| Total Stockholder Equity | 2,935,500,000USD | 4,319,400,000USD | 4,767,900,000USD | 4,842,100,000USD | 5,151,700,000USD | 5,655,100,000USD | 5,803,800,000USD | 5,668,000,000USD |
| Other Current Liab | 455,300,000USD | 495,200,000USD | 625,900,000USD | 497,300,000USD | 530,400,000USD | 855,800,000USD | 780,000,000USD | 775,800,000USD |
| Common Stock | 6,608,200,000USD | 6,733,900,000USD | 6,837,500,000USD | 6,936,700,000USD | 7,043,200,000USD | 7,118,200,000USD | 7,359,900,000USD | 7,421,700,000USD |
| Capital Stock | 6,608,200,000USD | 6,733,900,000USD | 6,837,500,000USD | 6,936,700,000USD | 7,043,200,000USD | 7,118,200,000USD | 7,359,900,000USD | 7,421,700,000USD |
| Retained Earnings | -3,677,500,000USD | -2,252,100,000USD | -2,080,300,000USD | -2,067,600,000USD | -1,927,000,000USD | -1,858,100,000USD | -1,695,500,000USD | -1,838,300,000USD |
| Good Will | 2,050,100,000USD | 3,320,200,000USD | 3,529,100,000USD | 3,490,400,000USD | 2,999,400,000USD | 3,095,700,000USD | 4,116,700,000USD | 4,029,100,000USD |
| Cash | 531,600,000USD | 558,800,000USD | 751,300,000USD | 600,700,000USD | 1,864,900,000USD | 631,500,000USD | 354,300,000USD | 551,100,000USD |
| Cash And Short Term Investments | 531,600,000USD | 558,800,000USD | 751,300,000USD | 600,700,000USD | 1,864,900,000USD | 631,500,000USD | 354,300,000USD | 551,100,000USD |
| Total Current Assets | 2,797,400,000USD | 2,481,900,000USD | 2,832,900,000USD | 2,719,900,000USD | 3,859,900,000USD | 3,133,500,000USD | 2,730,600,000USD | 2,902,200,000USD |
| Total Current Liabilities | 1,012,900,000USD | 1,044,200,000USD | 1,586,300,000USD | 1,113,600,000USD | 1,587,900,000USD | 1,382,000,000USD | 1,335,800,000USD | 1,537,400,000USD |
| Net Debt | 3,437,300,000USD | 3,059,300,000USD | 3,322,100,000USD | 3,723,800,000USD | 1,828,900,000USD | 3,094,200,000USD | 3,014,900,000USD | 2,691,300,000USD |
| Short Term Debt | 62,300,000USD | 36,400,000USD | 440,600,000USD | 64,600,000USD | 629,800,000USD | 65,600,000USD | 3,400,000USD | 190,200,000USD |
| Short Long Term Debt | 36,600,000USD | 36,400,000USD | 440,600,000USD | 36,200,000USD | 603,800,000USD | 37,800,000USD | 3,400,000USD | 190,200,000USD |
| Short Long Term Debt Total | 3,968,900,000USD | 3,618,100,000USD | 4,073,400,000USD | 4,324,500,000USD | 3,693,800,000USD | 3,725,700,000USD | 3,369,200,000USD | 3,242,400,000USD |
| Long Term Debt | 3,603,600,000USD | 3,581,700,000USD | 3,632,800,000USD | 4,070,400,000USD | 2,916,700,000USD | 3,528,300,000USD | 3,365,800,000USD | 3,052,200,000USD |
| Net Receivables | 612,800,000USD | 642,300,000USD | 739,600,000USD | 697,100,000USD | 652,900,000USD | 593,500,000USD | 1,243,200,000USD | 1,073,100,000USD |
| Inventory | 1,149,000,000USD | 1,081,800,000USD | 1,140,900,000USD | 1,150,300,000USD | 1,020,200,000USD | 1,059,400,000USD | 967,300,000USD | 878,000,000USD |
| Accounts Payable | 474,500,000USD | 495,200,000USD | 477,700,000USD | 537,300,000USD | 411,200,000USD | 451,600,000USD | 520,200,000USD | 474,900,000USD |
| Property Plant Equipment Net | 1,066,500,000USD | 1,093,000,000USD | 1,100,000,000USD | 1,143,400,000USD | 1,031,000,000USD | 1,019,300,000USD | 1,032,700,000USD | 829,100,000USD |
| Property Plant Equipment Gross | 2,326,000,000USD | 2,234,600,000USD | 2,172,400,000USD | 1,143,400,000USD | 1,031,000,000USD | 1,182,000,000USD | 1,032,700,000USD | — |
| Accumulated Other Comprehensive Income | 14,100,000USD | -162,400,000USD | 10,700,000USD | -27,000,000USD | 35,500,000USD | 395,000,000USD | 139,400,000USD | 84,600,000USD |
| Common Stock Shares Outstanding | 138,500,000shares | 137,400,000shares | 135,300,000shares | 134,500,000shares | 133,600,000shares | 136,100,000shares | 136,500,000shares | 138,300,000shares |
| Non Current Assets Total | 5,737,800,000USD | 7,165,800,000USD | 7,976,200,000USD | 8,297,400,000USD | 6,565,800,000USD | 8,354,900,000USD | 8,570,800,000USD | 8,081,200,000USD |
| Non Current Liabilities Total | 4,586,800,000USD | 4,284,100,000USD | 4,454,900,000USD | 5,061,600,000USD | 3,686,100,000USD | 4,451,300,000USD | 4,161,500,000USD | 3,777,900,000USD |
| Non Current Liabilities Other | 814,300,000USD | 499,200,000USD | 559,800,000USD | 623,000,000USD | 530,100,000USD | 643,700,000USD | 515,100,000USD | 443,400,000USD |
| Non Currrent Assets Other | 236,400,000USD | 318,600,000USD | 335,200,000USD | 367,700,000USD | 377,500,000USD | 1,710,800,000USD | 426,000,000USD | 343,400,000USD |
| Net Working Capital | 1,784,500,000USD | 1,437,700,000USD | 1,246,600,000USD | 1,606,300,000USD | 2,272,000,000USD | 1,751,500,000USD | 1,421,100,000USD | 1,364,800,000USD |
| Unclassified Current Liabilities | -15,800,000USD | -19,000,000USD | -398,500,000USD | -28,900,000USD | -1,127,300,000USD | -72,800,000USD | 28,800,000USD | -93,700,000USD |
| Unclassified Non Current Liabilities | 168,900,000USD | 203,200,000USD | 262,300,000USD | -433,500,000USD | -769,400,000USD | -923,000,000USD | -694,000,000USD | -725,700,000USD |
| Unclassified Equity | -6,617,500,000USD | -6,733,900,000USD | -6,837,500,000USD | -6,936,700,000USD | -7,043,200,000USD | -7,118,200,000USD | -7,359,900,000USD | -7,421,700,000USD |
| Current Deferred Revenue | — | — | -440,600,000USD | 7,100,000USD | 540,000,000USD | 44,000,000USD | — | — |
| Short Term Investments | — | — | 100,000USD | 100,000USD | 400,000USD | 2,500,000USD | 6,600,000USD | 9,400,000USD |
| Other Liab | — | — | — | 801,700,000USD | 769,400,000USD | 923,000,000USD | 694,000,000USD | 725,700,000USD |
| Other Assets | — | — | — | 240,200,000USD | 384,000,000USD | 3,576,000,000USD | 357,400,000USD | 344,600,000USD |
| Net Tangible Assets | — | — | — | -1,937,100,000USD | 900,000USD | 2,680,800,000USD | 2,882,600,000USD | 2,809,100,000USD |
| Unclassified Non Current Assets | — | — | — | -233,100,000USD | -377,500,000USD | -3,535,400,000USD | -372,100,000USD | -343,400,000USD |
| Deferred Long Term Liab | — | — | — | — | 239,300,000USD | 279,300,000USD | 280,600,000USD | 282,300,000USD |
| Long Term Investments | — | — | — | — | — | — | 20,100,000USD | 19,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -389,900,000USD | -1,414,500,000USD | 12,700,000USD | -500,000USD | 100,000USD | -44,500,000USD | -20,900,000USD | -108,400,000USD |
| Depreciation | 83,300,000USD | 55,700,000USD | 85,400,000USD | 86,300,000USD | 79,900,000USD | 80,300,000USD | 82,300,000USD | 81,900,000USD |
| Stock Based Compensation | 14,400,000USD | 13,000,000USD | 13,200,000USD | 16,800,000USD | 11,600,000USD | 19,900,000USD | 5,900,000USD | 23,000,000USD |
| Other Non Cash Items | 402,200,000USD | 1,412,200,000USD | 22,500,000USD | 15,600,000USD | 35,000,000USD | 71,800,000USD | 7,300,000USD | 92,900,000USD |
| Change To Account Receivables | -92,500,000USD | 26,100,000USD | 10,500,000USD | 59,300,000USD | -65,200,000USD | 58,200,000USD | -52,000,000USD | 34,600,000USD |
| Change To Inventory | 23,600,000USD | 82,600,000USD | -46,300,000USD | -34,900,000USD | -62,500,000USD | 28,400,000USD | -11,800,000USD | -13,500,000USD |
| Change In Working Capital | -196,300,000USD | 158,800,000USD | -45,300,000USD | -38,200,000USD | -176,400,000USD | 161,800,000USD | -17,600,000USD | -92,200,000USD |
| Total Cash From Operating Activities | -113,600,000USD | 175,400,000USD | 51,700,000USD | 75,900,000USD | -64,500,000USD | 312,600,000USD | 42,200,000USD | 9,500,000USD |
| Capital Expenditures | -13,800,000USD | -26,800,000USD | -21,900,000USD | -19,200,000USD | -25,500,000USD | -37,700,000USD | -27,100,000USD | -28,400,000USD |
| Free Cash Flow | -127,400,000USD | 148,600,000USD | 29,800,000USD | 56,700,000USD | -90,000,000USD | 274,900,000USD | 15,100,000USD | -18,900,000USD |
| Total Cashflows From Investing Activities | -12,400,000USD | -24,500,000USD | -21,400,000USD | -3,800,000USD | -25,700,000USD | -37,100,000USD | 212,700,000USD | -73,300,000USD |
| Net Borrowings | -424,300,000USD | -8,700,000USD | -8,500,000USD | -8,800,000USD | -8,800,000USD | -1,110,100,000USD | 691,900,000USD | — |
| Total Cash From Financing Activities | -45,300,000USD | -54,400,000USD | -50,300,000USD | -54,000,000USD | -61,800,000USD | -1,154,100,000USD | 653,300,000USD | -49,800,000USD |
| Dividends Paid | -39,900,000USD | -39,900,000USD | -39,900,000USD | -38,900,000USD | -40,600,000USD | -39,600,000USD | -37,600,000USD | -37,700,000USD |
| Change In Cash | -174,400,000USD | 99,500,000USD | -22,100,000USD | 44,300,000USD | -148,900,000USD | -904,700,000USD | 920,700,000USD | -115,700,000USD |
| Begin Period Cash Flow | 531,600,000USD | 432,100,000USD | 454,200,000USD | 409,900,000USD | 558,800,000USD | 1,463,500,000USD | 542,800,000USD | 658,500,000USD |
| End Period Cash Flow | 357,200,000USD | 531,600,000USD | 432,100,000USD | 454,200,000USD | 409,900,000USD | 558,800,000USD | 1,463,500,000USD | 542,800,000USD |
| Other Cashflows From Investing Activities | 1,400,000USD | 2,300,000USD | 500,000USD | 1,000,000USD | 1,300,000USD | -9,400,000USD | 34,300,000USD | -44,900,000USD |
| Other Cashflows From Financing Activities | -3,200,000USD | -5,800,000USD | -1,900,000USD | -6,300,000USD | -12,400,000USD | 300,000USD | -1,000,000USD | -2,300,000USD |
| Unclassified Operating Cash Flow | -27,300,000USD | -49,800,000USD | -36,800,000USD | -4,100,000USD | -14,700,000USD | 23,300,000USD | -14,800,000USD | 12,300,000USD |
| Unclassified Financing Cash Flow | 422,100,000USD | — | — | — | — | — | — | -9,800,000USD |
| Investments | — | 0USD | -21,400,000USD | -3,800,000USD | -25,700,000USD | -37,100,000USD | 212,700,000USD | -73,300,000USD |
| Unclassified Investing Cash Flow | — | — | 21,400,000USD | 18,200,000USD | 24,200,000USD | 47,100,000USD | -7,200,000USD | 73,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -1,402,300,000USD | -171,800,000USD | -12,700,000USD | -140,600,000USD | -68,900,000USD | -162,600,000USD | 146,100,000USD | 131,000,000USD |
| Depreciation | 337,500,000USD | 325,900,000USD | 359,500,000USD | 338,600,000USD | 312,200,000USD | 384,800,000USD | 396,500,000USD | 423,600,000USD |
| Stock Based Compensation | 54,600,000USD | 64,400,000USD | 68,800,000USD | 54,900,000USD | 60,100,000USD | 58,500,000USD | 52,200,000USD | 37,700,000USD |
| Other Non Cash Items | 1,455,200,000USD | 209,300,000USD | 155,000,000USD | 84,900,000USD | 138,900,000USD | 479,200,000USD | 150,400,000USD | 38,000,000USD |
| Change To Account Receivables | 30,700,000USD | -11,100,000USD | -57,100,000USD | 100,000USD | -159,700,000USD | 168,900,000USD | -140,700,000USD | 21,000,000USD |
| Change To Inventory | -61,100,000USD | 13,700,000USD | 19,400,000USD | -76,700,000USD | -2,400,000USD | -170,600,000USD | -67,000,000USD | -98,600,000USD |
| Change In Working Capital | -101,100,000USD | -74,700,000USD | -58,500,000USD | 20,000,000USD | -295,400,000USD | -69,200,000USD | -313,500,000USD | -19,400,000USD |
| Total Cash From Operating Activities | 238,500,000USD | 362,900,000USD | 405,500,000USD | 307,300,000USD | 156,300,000USD | 636,200,000USD | 387,800,000USD | 593,000,000USD |
| Capital Expenditures | -93,400,000USD | -118,300,000USD | -101,700,000USD | -96,400,000USD | -152,100,000USD | -170,400,000USD | -137,700,000USD | -102,600,000USD |
| Free Cash Flow | 145,100,000USD | 244,600,000USD | 303,800,000USD | 210,900,000USD | 4,200,000USD | 465,800,000USD | 250,100,000USD | 490,400,000USD |
| Investments | 0USD | 78,800,000USD | -80,700,000USD | -1,958,600,000USD | 1,275,800,000USD | -15,000,000USD | -596,100,000USD | -7,500,000USD |
| Total Cashflows From Investing Activities | -75,400,000USD | 78,800,000USD | -77,500,000USD | -1,958,600,000USD | 1,275,800,000USD | -187,800,000USD | -596,100,000USD | -126,800,000USD |
| Net Borrowings | -34,800,000USD | -437,800,000USD | -30,200,000USD | 616,700,000USD | -30,600,000USD | 124,200,000USD | 123,500,000USD | -58,300,000USD |
| Total Cash From Financing Activities | -220,500,000USD | -611,000,000USD | -187,200,000USD | 421,600,000USD | -178,700,000USD | -181,100,000USD | 1,800,000USD | -571,900,000USD |
| Dividends Paid | -159,300,000USD | -152,500,000USD | -149,700,000USD | -142,400,000USD | -129,600,000USD | -123,900,000USD | -112,400,000USD | -104,900,000USD |
| Change In Cash | -27,200,000USD | -192,500,000USD | 150,600,000USD | -1,264,200,000USD | 1,233,400,000USD | 287,200,000USD | -196,800,000USD | -127,600,000USD |
| Begin Period Cash Flow | 558,800,000USD | 751,300,000USD | 600,700,000USD | 1,864,900,000USD | 631,500,000USD | 354,300,000USD | 551,100,000USD | 678,700,000USD |
| End Period Cash Flow | 531,600,000USD | 558,800,000USD | 751,300,000USD | 600,700,000USD | 1,864,900,000USD | 641,500,000USD | 354,300,000USD | 551,100,000USD |
| Other Cashflows From Investing Activities | 18,000,000USD | 197,100,000USD | 24,200,000USD | 61,700,000USD | 2,800,000USD | -2,400,000USD | -309,300,000USD | -35,600,000USD |
| Other Cashflows From Financing Activities | -26,400,000USD | -20,700,000USD | -7,300,000USD | 1,522,900,000USD | -49,100,000USD | -23,900,000USD | -11,200,000USD | -10,000,000USD |
| Unclassified Operating Cash Flow | -105,400,000USD | 9,800,000USD | -106,600,000USD | -50,500,000USD | 9,400,000USD | -54,500,000USD | -43,900,000USD | -17,900,000USD |
| Unclassified Investing Cash Flow | — | -78,800,000USD | 80,700,000USD | 34,700,000USD | 149,300,000USD | — | 447,000,000USD | 18,900,000USD |
| Change To Liabilities | — | — | — | 100,300,000USD | -7,900,000USD | -2,700,000USD | 17,000,000USD | 28,800,000USD |
| Sale Purchase Of Stock | — | — | — | 0USD | 0USD | -164,200,000USD | 600,500,000USD | -400,000,000USD |
| Unclassified Financing Cash Flow | — | — | — | -1,575,600,000USD | 30,600,000USD | 6,700,000USD | -598,600,000USD | — |
| Issuance Of Capital Stock | — | — | — | — | 0USD | 200,000USD | 900,000USD | 1,300,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 1,253,400,000USD | 267,300,000USD | -206,500,000USD | -127,600,000USD |
| Exchange Rate Changes | — | — | — | — | — | — | — | -21,900,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-27 | Geography | Europe | 371,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Geography | IE | 7,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Geography | Other Geographical Areas | 24,700,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Geography | United States | 626,400,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Segment | Infant Formula | 100,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Segment | Self Care | 576,600,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-27 | Segment | Specialty Care | 226,600,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 391,400,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Geography | IE | 4,100,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Other Geographical Areas | 23,400,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 554,400,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Infant Formula | 89,700,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Self Care | 543,300,000 | USD | 0001585364-26-000048 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Specialty Care | 207,000,000 | USD | 0001585364-26-000048 |
| Q4 2025Quarterly · 2025-12-31 | Segment | Consumer Self Care Americas | 697,000,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Consumer Self Care International | 412,600,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 1,616,300,000 | USD | 0001585364-26-000009 |
| FY 2025Yearly · 2025-12-31 | Geography | IE | 42,100,000 | USD | 0001585364-26-000009 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Geographical Areas | 96,700,000 | USD | 0001585364-26-000009 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 2,540,100,000 | USD | 0001585364-26-000009 |
| FY 2025Yearly · 2025-12-31 | Segment | Consumer Self Care Americas | 2,585,300,000 | USD | 0001585364-26-000009 |
| FY 2025Yearly · 2025-12-31 | Segment | Consumer Self Care International | 1,667,700,000 | USD | 0001585364-26-000009 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Europe | 384,000,000 | USD | 0001585364-25-000156 |
| Q3 2025Quarterly · 2025-09-30 | Geography | IE | 8,600,000 | USD | 0001585364-25-000156 |
| Q3 2025Quarterly · 2025-09-30 | Geography | Other Geographical Areas | 24,000,000 | USD | 0001585364-25-000156 |
| Q3 2025Quarterly · 2025-09-30 | Geography | United States | 635,300,000 | USD | 0001585364-25-000156 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Consumer Self Care Americas | 645,600,000 | USD | 0001585364-25-000156 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Consumer Self Care International | 397,700,000 | USD | 0001585364-25-000156 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Europe | 421,700,000 | USD | 0001585364-25-000122 |
| Q2 2025Quarterly · 2025-06-30 | Geography | IE | 9,800,000 | USD | 0001585364-25-000122 |
| Q2 2025Quarterly · 2025-06-30 | Geography | Other Geographical Areas | 23,700,000 | USD | 0001585364-25-000122 |
| Q2 2025Quarterly · 2025-06-30 | Geography | United States | 610,900,000 | USD | 0001585364-25-000122 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Consumer Self Care Americas | 622,000,000 | USD | 0001585364-25-000122 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Consumer Self Care International | 434,300,000 | USD | 0001585364-25-000122 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Infant Formula | 87,800,000 | USD | 0001585364-26-000048 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Self Care | 614,300,000 | USD | 0001585364-26-000048 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Specialty Care | 199,100,000 | USD | 0001585364-26-000048 |
| Q4 2024Quarterly · 2024-12-31 | Segment | Consumer Self Care Americas | 744,200,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Consumer Self Care International | 394,100,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 1,604,600,000 | USD | 0001585364-26-000009 |
| FY 2024Yearly · 2024-12-31 | Geography | IE | 39,600,000 | USD | 0001585364-26-000009 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Geographical Areas | 119,500,000 | USD | 0001585364-26-000009 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 2,649,300,000 | USD | 0001585364-26-000009 |
| FY 2024Yearly · 2024-12-31 | Segment | Consumer Self Care Americas | 2,693,700,000 | USD | 0001585364-26-000009 |
| FY 2024Yearly · 2024-12-31 | Segment | Consumer Self Care International | 1,679,600,000 | USD | 0001585364-26-000009 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Consumer Self Care Americas | 671,300,000 | USD | 0001585364-25-000156 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Consumer Self Care International | 416,300,000 | USD | 0001585364-25-000156 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Europe | 419,700,000 | USD | 0001585364-25-000056 |
| Q1 2024Quarterly · 2024-03-31 | Geography | IE | 4,300,000 | USD | 0001585364-25-000056 |
| Q1 2024Quarterly · 2024-03-31 | Geography | Other Geographical Areas | 30,100,000 | USD | 0001585364-25-000056 |
| Q1 2024Quarterly · 2024-03-31 | Geography | United States | 632,300,000 | USD | 0001585364-25-000056 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 1,622,500,000 | USD | 0001585364-26-000009 |
| FY 2023Yearly · 2023-12-31 | Geography | IE | 40,800,000 | USD | 0001585364-26-000009 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Geographical Areas | 116,300,000 | USD | 0001585364-26-000009 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 2,916,800,000 | USD | 0001585364-26-000009 |
| FY 2023Yearly · 2023-12-31 | Segment | Consumer Self Care Americas | 2,962,300,000 | USD | 0001585364-24-000009 |
| FY 2023Yearly · 2023-12-31 | Segment | Consumer Self Care International | 1,693,300,000 | USD | 0001585364-24-000009 |
| FY 2023Yearly · 2023-12-31 | Segment | RXPharmaceuticals | 0 | USD | 0001585364-24-000009 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Europe | 425,700,000 | USD | 0001585364-24-000113 |
| Q2 2023Quarterly · 2023-06-30 | Geography | IE | 11,900,000 | USD | 0001585364-24-000113 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Other Geographical Areas | 31,600,000 | USD | 0001585364-24-000113 |
| Q2 2023Quarterly · 2023-06-30 | Geography | United States | 735,800,000 | USD | 0001585364-24-000113 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Europe | 407,300,000 | USD | 0001585364-24-000070 |
| Q1 2023Quarterly · 2023-03-31 | Geography | IE | 7,300,000 | USD | 0001585364-24-000070 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Other Geographical Areas | 24,400,000 | USD | 0001585364-24-000070 |
| Q1 2023Quarterly · 2023-03-31 | Geography | United States | 750,000,000 | USD | 0001585364-24-000070 |
| Q4 2022Quarterly · 2022-12-31 | Geography | Europe | 375,600,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Geography | IE | 9,200,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Geography | Other Geographical Areas | 26,400,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Geography | United States | 753,200,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 1,474,300,000 | USD | 0001585364-25-000014 |
| FY 2022Yearly · 2022-12-31 | Geography | IE | 29,300,000 | USD | 0001585364-25-000014 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Geographical Areas | 107,300,000 | USD | 0001585364-25-000014 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 2,870,000,000 | USD | 0001585364-25-000014 |
| FY 2022Yearly · 2022-12-31 | Segment | Consumer Self Care Americas | 2,925,900,000 | USD | 0001585364-24-000009 |
| FY 2022Yearly · 2022-12-31 | Segment | Consumer Self Care International | 1,525,700,000 | USD | 0001585364-24-000009 |
| FY 2022Yearly · 2022-12-31 | Segment | RXPharmaceuticals | 0 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 1,393,000,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | IE | 23,700,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | Other Geographical Areas | 179,800,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 2,565,900,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Segment | Consumer Self Care Americas | 2,693,100,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Segment | Consumer Self Care International | 1,445,600,000 | USD | 0001585364-24-000009 |
| FY 2021Yearly · 2021-12-31 | Segment | RXPharmaceuticals | 0 | USD | 0001585364-24-000009 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 1,350,600,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Geography | IE | 29,800,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Geographical Areas | 158,600,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 2,579,000,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Segment | Consumer Self Care Americas | 2,693,000,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Segment | Consumer Self Care International | 1,395,200,000 | USD | 0001585364-23-000006 |
| FY 2020Yearly · 2020-12-31 | Segment | RXPharmaceuticals | 0 | USD | 0001585364-23-000006 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 1,335,800,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Geography | IE | 23,400,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Geographical Areas | 173,800,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 2,360,300,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Segment | Consumer Self Care Americas | 2,487,700,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Segment | Consumer Self Care International | 1,382,200,000 | USD | 0001585364-22-000011 |
| FY 2019Yearly · 2019-12-31 | Segment | RXPharmaceuticals | 0 | USD | 0001585364-22-000011 |
| FY 2018Yearly · 2018-12-31 | Geography | Europe | 1,347,600,000 | USD | 0001585364-21-000012 |
| FY 2018Yearly · 2018-12-31 | Geography | IE | 25,700,000 | USD | 0001585364-21-000012 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.